AUTHOR=Adkins Chris E., Mittapalli Rajendar K., Manda Vamshi K., Nounou Mohamed I., Mohammad Afroz S., Terrrell Tori B., Bohn Kaci A., Yasemin Celik , Grothe Tiffany R., Lockman Julie A., Lockman Paul R. TITLE=P-glycoprotein mediated efflux limits substrate and drug uptake in a preclinical brain metastases of breast cancer model JOURNAL=Frontiers in Pharmacology VOLUME=4 YEAR=2013 URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2013.00136 DOI=10.3389/fphar.2013.00136 ISSN=1663-9812 ABSTRACT=
The blood–brain barrier (BBB) is a specialized vascular interface that restricts the entry of many compounds into brain. This is accomplished through the sealing of vascular endothelial cells together with tight junction proteins to prevent paracellular diffusion. In addition, the BBB has a high degree of expression of numerous efflux transporters which actively extrude compounds back into blood. However, when a metastatic lesion develops in brain the vasculature is typically compromised with increases in passive permeability (blood-tumor barrier; BTB). What is not well documented is to what degree active efflux retains function at the BTB despite the changes observed in passive permeability. In addition, there have been previous reports documenting both increased and decreased expression of P-glycoprotein (P-gp) in lesion vasculature. Herein, we simultaneously administer a passive diffusion marker (14C-AIB) and a tracer subject to P-gp efflux (rhodamine 123) into a murine preclinical model of brain metastases of breast cancer. We observed that the metastatic lesions had similar expression (